XML 79 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK PLANS (Details 3) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2014
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Share-based Compensation arrangement by Share-based payment award, equity instruments others than options, vested and expected to vest, weighted average grant date fair value $ 42.14        
share-based compensation arrangement by share-based payment award, equity instruments other than options, vested and expected to vest, aggregate intrinsic value $ 24,864        
Stock options          
Number of Shares          
Balance at the beginning of the period (in shares) 4,951,493 5,207,743 4,645,722    
Granted (in shares) 1,994,332 1,072,625 1,656,598    
Exercised (in shares) (332,732) (539,989) (518,226)    
Forfeited (in shares) (481,126) (555,897) (401,048)    
Expired (in shares) (409,149) (232,989) (175,303)    
Balance at the end of the period (in shares) 5,722,818 4,951,493 5,207,743    
Exercisable at the end of the period (in shares) 3,009,133        
Vested and expected to vest at the end of the period (in shares) 5,722,818        
Weighted Average Exercise Price          
Balance at the beginning of the period (in dollars per share) $ 43.51 $ 42.16 $ 44.03    
Granted (in dollars per share) 39.35 43.93 38.20    
Exercised (in dollars per share) 21.55 12.55 11.13    
Forfeited (in dollars per share) 42.30 48.66 70.27    
Expired (in dollars per share) 68.01 74.65 80.91    
Balance at the end of the period (in dollars per share) 41.69 $ 43.51 $ 42.16    
Exercisable at the end of the period (in dollars per share) 43.03        
Vested and expected to vest at the end of the period (in dollars per share) $ 41.69        
Weighted Average remaining contractual term          
Balance at the end of the period 7 years 24 days 6 years 10 months 27 days 7 years 4 months 22 days 7 years 3 months 22 days  
Exercisable at the end of the period 5 years 4 months 16 days        
Vested and expected to vest at the end of the period 7 years 24 days        
Aggregate intrinsic value          
Balance at the beginning of the period (in dollars) $ 57,021 $ 37,581 $ 162,340    
Exercised (in dollars) 7,418 15,865 21,750    
Balance at the end of the period (in dollars) 49,166 $ 57,021 $ 37,581    
Exercisable at the end of the period (in dollars) 37,629        
Vested and expected to vest at the end of the period (in dollars) $ 49,166        
Weighted average assumptions used to estimate the fair values of each option grant          
Risk free interest rate, minimum (as a percent) 2.26% 1.68% 1.03%    
Risk free interest rate, maximum (as a percent) 3.05% 2.42% 2.48%    
Expected volatility (as a percent) 53.30% 51.40% 53.50%    
Expected life of options 5 years 1 month 19 days 5 years 3 months 21 days 5 years 9 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 19.34 $ 20.78 $ 19.13    
Restricted Stock Units (RSUs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 499,546 364,403 216,198    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 331,129 343,583 256,631    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (156,450) (101,379) (61,487)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (96,261) (107,061) (46,939)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 577,964 499,546 364,403    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 47.32 $ 52.85 $ 78.59    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 38.36 44.23 40.21    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value 49.59 53.76 78.33    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 43.92 49.98 68.84    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 42.14 $ 47.32 $ 52.85    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 24,864 $ 22,804 $ 11,824   $ 16,602
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest 577,964,000        
Stock options          
Weighted average assumptions used to estimate the fair values of each option grant          
Expected volatility (as a percent) 52.20% 53.80% 63.40%    
Expected life of options 6 months 6 months 6 months    
Stock options | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 13.15 $ 13.85 $ 10.57    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1.53% 1.14% 0.37%    
Stock options | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 10.40 $ 10.80 $ 25.28    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 2.14% 0.62% 0.49%